These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge. Johnson TR; Parker RA; Johnson JE; Graham BS J Immunol; 2003 Feb; 170(4):2037-45. PubMed ID: 12574374 [TBL] [Abstract][Full Text] [Related]
6. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. Castilow EM; Meyerholz DK; Varga SM J Immunol; 2008 Feb; 180(4):2376-84. PubMed ID: 18250447 [TBL] [Abstract][Full Text] [Related]
7. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. Srikiatkhachorn A; Braciale TJ J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194 [TBL] [Abstract][Full Text] [Related]
8. Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses. Mebratu YA; Smith KR; Agga GE; Tesfaigzi Y Respir Res; 2016 Jul; 17(1):75. PubMed ID: 27363862 [TBL] [Abstract][Full Text] [Related]
9. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells. Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098 [TBL] [Abstract][Full Text] [Related]
10. CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV). Hancock GE; Heers KM; Smith JD; Scheuer CA; Ibraghimov AR; Pryharski KS Vaccine; 2001 Sep; 19(32):4874-82. PubMed ID: 11535341 [TBL] [Abstract][Full Text] [Related]
11. Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice. Boelen A; Andeweg A; Kwakkel J; Lokhorst W; Bestebroer T; Dormans J; Kimman T Vaccine; 2000 Nov; 19(7-8):982-91. PubMed ID: 11115725 [TBL] [Abstract][Full Text] [Related]
12. Effect of preexposure to ultrafine carbon black on respiratory syncytial virus infection in mice. Lambert AL; Trasti FS; Mangum JB; Everitt JI Toxicol Sci; 2003 Apr; 72(2):331-8. PubMed ID: 12660365 [TBL] [Abstract][Full Text] [Related]
13. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease. Spender LC; Hussell T; Openshaw PJ J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139 [TBL] [Abstract][Full Text] [Related]